Autoinjectorshave become an important part of modern healthcare, having demonstrated thepotential to address a number of parenteral drug delivery related adverseevents, and improve medication adherence among patients
RootsAnalysis is pleased to announce the publication of its recent study, titled,“Global AutoinjectorsMarket (3rd Edition), 2020-2030.”
Thereport features an extensive study of the current market landscape, offering aninformed opinion on the likely adoption of autoinjectors over the next decade.The report features an in-depth analysis, highlighting the diverse capabilitiesof stakeholders engaged in this domain. In addition to other elements, thestudy includes:
· A detailed assessment of the current marketlandscape of developers engaged in the development and / or manufacturingautoinjectors.
· A detailed assessment of current landscape ofcompanies that are developing drugs in combination with autoinjectors.
· A competitiveness analysis of variousdisposable and reusable autoinjectors.
· A detailed brand positioning analysis ofleading industry players highlighting the current perceptions regarding theirproprietary brands.
· A list of marketed drugs / therapies andpipeline candidates that are likely to be developed in combination withautoinjectors in the near future.
· A list of key opinion leaders (KOLs) withinthis domain with significant contributions in clinical trials and filing patentapplications.
· Detailed case studies on the most commonlytargeted indications of the approved autoinjector products.
· A case study on the role of CMOs offeringservices for drug delivery devices.
· A SWOT analysis capturing the key parametersand trends that are likely to influence the future of autoinjectors market.
· Elaborate profiles of autoinjectormanufacturers that have more than three devices in their respective productportfolios.
Adetailed market forecast, featuring analysis of the current and projectedfuture opportunity across key market segments (listed below)
Usability
· Disposable
· Reusable
Routeof Administration
· Subcutaneous
· Intramuscular
Typeof Molecule
· Monoclonal Antibody
· Peptide
· Protein
· Small Molecule
TherapeuticIndication
· Anaphylaxis
· Asthma
· Multiple Sclerosis
· Rheumatoid Arthritis
· Migraine
· Diabetes
· Other Indications
KeyGeographies
· North America
· Europe
· Asia-Pacific
· Rest of the World
The research, analysis and insights presented in thisreport are backed by a deep understanding of key insights gathered from bothsecondary and primary research. The opinions and insights presented in thereport were influenced by discussions held with several players in thisindustry. The study includes detailed transcripts of discussions held with thefollowing individuals:
· David Daily (CEO and Co-founder, DALI MedicalDevices)
· Dennis Lee (Senior Program Officer in CMC,Bill & Melinda Gates Foundation)
· Douglas Marenzi (Managing Director, PHCInjection Technologies)
· Tsachi Shaked (Senior Marketing and BDDirector, Injectable Drug Delivery Devices, Elcam Medical)
· Jesse Fourt (Design Director, IDEO)
Keycompanies covered in the report
· Antares Pharma
· Consort Medical (Previously Bespak)
· DALI Medical Devices
· Elcam Medical (E3D Elcam Drug DeliveryDevices)
· Jiangsu Delfu Medical Devices
· Oval Medical Technologies
· Owen Mumford
· SHL Group
· Union Medico®
· Ypsomed
Askfor Sample:
https://www.rootsanalysis.com/reports/293/request-sample.html
AboutRoots Analysis
RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
ContactInformation
RootsAnalysis Private Limited
GauravChaudhary
+1(415) 800 3415
Gaurav.Chaudhary@rootsanalysis.com
AlsoVisit Our Latest Publication
In Silico / Computer-Aided DrugDiscovery Services Market
Antibody Contract Manufacturing Market
Biopharma Contract Manufacturing Market
Cell Therapy Manufacturing Market
